PST-611, a first in class non-viral vectorized therapy expressing human transferrin, a highly potent iron regulator.

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

1 Department of Medicine, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Medical Center, Columbus, Ohio, USA Background The mechanisms underlying chronic obstructive ...

Chronic pain has been widely recognized as a major public health problem that impacts multiple aspects of patient quality of life. Unfortunately, chronic pain is often resistant to conventional ...

Standardized MRI acquisition protocols are crucial for reducing the measurement and interpretation variability associated with response assessment in brain tumor clinical trials. The main challenge is ...

Fisheries and Oceans Canada, Pacific Science Enterprise Center, 4160 Marine Drive, West Vancouver, British Columbia V7V 1N6, Canada ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. The amino-terminal domain of collagen α1(XI) plays a key role in controlling ...